Neurogene
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-925 |
Gross Profit | -812 | -762 | -15,347 | |
EBITDA | -20,176 | -21,248 | -21,883 | -20,714 |
EBIT | -20,952 | -22,015 | -22,645 | -21,512 |
Net Income | -20,953 | -22,016 | -22,647 | -19,514 |
Net Change In Cash | 0 | 0 | 0 | -925 |
Free Cash Flow | -19,808 | -19,610 | -21,554 | -17,612 |
Cash | 71,005 | 58,813 | 70,771 | 136,586 |
Basic Shares | 21,168 | 21,055 | 20,996 | 14,854 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $925 | $0 | $0 | $0 |
Gross Profit | -2,322 | -3,262 | -3,196 | -42,264 |
EBITDA | -71,885 | -52,286 | -51,991 | -49,587 |
EBIT | -75,132 | -55,583 | -55,187 | -50,534 |
Net Income | -75,144 | -36,317 | -55,189 | -50,517 |
Net Change In Cash | 925 | 0 | 0 | 0 |
Free Cash Flow | -71,411 | -51,743 | -55,054 | -64,769 |
Cash | 136,586 | 148,210 | 82,021 | 70,544 |
Basic Shares | 17,567 | 12,823 | 12,823 | 55,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.99 |
2025-06-30 | -$1.05 |
2025-03-31 | -$1.08 |
2024-12-31 | -$0.99 |
